Description du poste
Epistemic status: CellAg Germany and its nonprofit initiative AltProtein.Jobs (“we” from now on) operate in the alt protein sector. We are here arguing for our own cause area; this post reflects our organization’s view that alternative proteins remain one of the most impactful and promising paths for animal welfare, particularly when complemented by other welfare initiatives. We have done our best to engage honestly with the past counterarguments and to present data rather than advocacy where possible.
This post was authored by Nadja Milivojev, and contributed to by Liliia Lisina and Pia Voltz. We extend our gratitude to Helene Grosshans from GFI Europe for providing valuable feedback and personal opinions on this piece.
TL;DRWe raise a case for alternative proteins as an impactful path to reducing animal suffering. Within this field, a neglected and time-sensitive opportunity is the institutional layer needed to turn scientific progress into durable food system change.
• The alt protein sector is politically and financially vulnerable: private investment has contracted sharply, public funding still overwhelmingly supports animal agriculture, and restrictive policies could strand existing capacity;• The bottleneck has been shifting away from technology: policy, talent placement, public procurement, corporate reformulation, and market-shaping remain underfunded relative to R&D;• Europe faces a narrow policy window: Common Agricultural Policy, Biotech Act II, and Germany’s Food and Nutrition Strategy will shape the food and agricultural policy in EU Member States for years. Not placing and activating alt protein advocates in relevant institutions risks locking in the status quo;• AI keeps raising the stakes: AI may accelerate alt protein R&D, but could also make factory farming cheaper and more intensive. Additionally, it is unlikely to solve regulatory and advocacy bottlenecks soon, so human action is needed;• Impact does not require mass consumer conversion: B2B ing